Healthcare

With this research service, Frost & Sullivan’s Healthcare and Life Sciences team provides critical insights into the European Union and UK COVID-19 vaccine and therapeutics market. The report analyzes COVID-19 vaccines and therapeutics in development and delves into supply chain considerations and requirements to manage distribution. Importantly,...

Rising healthcare and surgery costs are increasing the burden on healthcare systems, making it difficult for hospitals to offer high-quality care at affordable prices. Time-consuming manual processes that significantly impact surgeon time and workload, hospital cost increases due to delayed surgery, and low patient satisfaction levels due to human ...

The Frost & Sullivan research service discusses the cell and gene therapy (CGT) market and highlights some key roadblocks in viral vector manufacturing. While many CGT candidates exist in the pipeline, there is a huge capacity deficit that the industry is collaboratively trying to address. Scalability, costs, reproducibility, and overall process ef...

Connected medical devices are experiencing major interest from the healthcare industry because of their ability to integrate digital technologies, link with smartphones and online platforms, and share data. Advanced and small-sized sensors are set to accelerate the miniaturization of connected medical devices and improve their accuracy. As such, sm...

RNA therapeutics is a rapidly expanding field of next-generation medicine. RNA therapy typically comprises 4 different classes of molecules: non-codingRNA (ncRNA), antisense oligonucleotide (ASO), messengerRNA (mRNA), and RNA aptamer. Small ncRNAs are like a double-edged sword; they can either up- or down-regulate specific genes. Contrarily, long...

The COVID-19 pandemic has not only revealed supply chain challenges in terms of meeting pandemic-induced demand but also showcased weaknesses with regard to facing disruptions on a global scale. Immediate impacts include supply volatility, steep price increases, and high levels of uncertainty. Despite the manufacturing reboot, supply chain inter...

The healthcare industry has been adapting to changes induced by the COVID-19 pandemic. Medtech, for its part, has been pursuing mergers and acquisitions (M&As) to implement reforms and help the industry recover. Companies in the traditional clinical segments in medtech, such as orthopedics, cardiology, ear, nose, and throat (ENT), wound care, urolo...

The electrophysiology (EP) service line has grown leaps and bounds in the past decade, driven by factors including advancement in interventional imaging, improvement in catheters for effective ablation therapy, and the introduction of robotic navigation systems for supporting safe and efficient procedures. The demand for minimally invasive EP proce...

Wounds, especially chronic wounds, are associated with clinical, social, and economic challenges. Wounds resulting from diabetes, injuries, and surgeries affect a significant population globally. According to an economic evaluation study on Medicare beneficiaries, 8.2 million people in the United States have at least one type of chronic wound. Amon...